Inspire Medical Systems announced that the Blue Cross Blue Shield Association’s Evidence Street issued a positive assessment of Inspire therapy to its members. BCBSA is a national federation of 36 Blue Cross and Blue Shield companies that, when combined, is one of the leading health associations in the U.S. The report summarized that sufficient evidence exists to determine that hypoglossal nerve stimulation results in a meaningful improvement in the net health outcome for patients meeting the following selection criteria.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.